Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences
Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences CHESTERBROOK, Pa., Jan. 07, 2021 — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate in two upcoming virtual investor conferences, with additional details below. About Trevena Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders. T...